Browse
related articles
Ministry of Health and Lamisil collaborate to help the quarter of UAE nationals suffering from diabetes
- United Arab Emirates: Tuesday, November 14 - 2006 at 12:22
- PRESS RELEASE
A poster developed by Novartis for Lamisil and endorsed by the Ministry of Health is to be distributed on World Diabetes Day.
Our sedentary lifestyles and bad eating habits are being blamed for the disease that constitutes 75% of the death among UAE nationals but only 31% among our non-national residents. With even children as young as ten being diagnosed with what was once an adults-only disease, diabetes has become one of the main priorities of the Ministry of Health.
Lamisil is teaming with the MoH to make people aware that foot complications could be one of the important reasons for hospitalisation in patients with diabetes - with risk of amputation 46 times higher in diabetics. If attention is not paid to proper foot care and treatment, a common and highly contagious infection such as athlete's foot can result in loss of limb. Across the world, every 30 seconds a leg is lost to diabetes...
Characterised by itchy, flaky feet that blister or burn, athlete's foot causes the skin on the foot to crack, enabling germs to enter and breed. If untreated, gangrene and ultimately amputation may take place.
As highlighted by the posters, effective treatment and early detection of diabetes are fundamental.
Unlike most topical antifungal treatments which simply stop the fungus growing (fungistatic), once-daily Lamisil Spray or Cream also kills the fungus (fungicidal) and provides long-term protection against re-infection.
Ideal management for the prevention and treatment of diabetic foot problems includes:
• Regular inspection of the feet
• Education of people with diabetes and healthcare professionals
• Appropriate footwear
• Rapid treatment of all foot problems
Also consider reading:
Browse
related articles
Notes and media contacts
For further information please contact:Rawaa Abdalla
TRACCS Public Relations
Tel: + 971 4 367 2528
Fax: + 971 4 367 2531
Disclaimer:
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions

Posted by Lara Lynn Golden, News Editor
